SIROLIMUS (SLR) THERAPY IN KIDNEY RECIPIENTS WITH PAST CANCER PREVENTS RECURRENCE OF CANCER AFTER TRANSPLANTATION: 3 YEAR POST TRANSPLANT EXPERIENCE.

Publication/Presentation Date

2005

Volume

5

Issue

11

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery

Document Type

Article

Share

COinS